NADPH oxidases in Parkinson’s disease: a systematic review

Abstract : AbstractParkinson’s disease (PD) is a progressive movement neurodegenerative disease associated with a loss of dopaminergic neurons in the substantia nigra of the brain. Oxidative stress, a condition that occurs due to imbalance in oxidant and antioxidant status, is thought to play an important role in dopaminergic neurotoxicity. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidases are multi-subunit enzymatic complexes that generate reactive oxygen species as their primary function. Increased immunoreactivities for the NADPH oxidases catalytic subunits Nox1, Nox2 and Nox4 have been reported in the brain of PD patients. Furthermore, knockout or genetic inactivation of NADPH oxidases exert a neuroprotective effect and reduce detrimental aspects of pathology in experimental models of the disease. However, the connections between NADPH oxidases and the biological processes believed to contribute to neuronal death are not well known. This review provides a comprehensive summary of our current understanding about expression and physiological function of NADPH oxidases in neurons, microglia and astrocytes and their pathophysiological roles in PD. It summarizes the findings supporting the role of both microglial and neuronal NADPH oxidases in cellular disturbances associated with PD such as neuroinflammation, alpha-synuclein accumulation, mitochondrial and synaptic dysfunction or disruption of the autophagy-lysosome system. Furthermore, this review highlights different steps that are essential for NADPH oxidases enzymatic activity and pinpoints major obstacles to overcome for the development of effective NADPH oxidases inhibitors for PD.
Type de document :
Article dans une revue
Molecular Neurodegeneration, BioMed Central, 2016, 12 (1), pp.84. 〈10.1186/s13024-017-0225-5〉
Liste complète des métadonnées

Littérature citée [188 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01638055
Contributeur : Bmc Bmc <>
Soumis le : dimanche 19 novembre 2017 - 05:28:56
Dernière modification le : mardi 3 juillet 2018 - 11:27:06
Document(s) archivé(s) le : mardi 20 février 2018 - 12:14:58

Fichier

13024_2017_Article_225.pdf
Publication financée par une institution

Identifiants

Collections

Citation

Karim Belarbi, Elodie Cuvelier, Alain Destée, Bernard Gressier, Marie-Christine Chartier-Harlin. NADPH oxidases in Parkinson’s disease: a systematic review. Molecular Neurodegeneration, BioMed Central, 2016, 12 (1), pp.84. 〈10.1186/s13024-017-0225-5〉. 〈inserm-01638055〉

Partager

Métriques

Consultations de la notice

67

Téléchargements de fichiers

23